Tongji Hospital in Wuhan in China
April 7, 2022 — RaySearch Laboratories AB announces that Mevion China has placed an order for RayStation which Mevion China has sold together with Mevion’s HYPERSCAN proton therapy system to Tongji Hospital in Wuhan in China. RaySearch and Mevion have been collaborating since 2014. Treatment planning for particle treatments (protons/carbon ions/BNCT) is an important focus area for RaySearch and today RayStation has a global market share of more than 50 percent, a position that is further strengthened by the new order.
RaySearch has about 70 RayStation customers in China through its own subsidiary in the country.
Xianglin Yuan, Executive Director of the Radiotherapy Department of Wuhan Tongji Hospital, says: “Our Optics Valley Campus Proton Therapy Center has been equipped with Mevion S250 proton therapy system and RaySearch's treatment planning system RayStation to jointly build a world-leading proton therapy research center and a base for cooperation between medical science and the industry, creating a new level for proton therapy.”
Johan Löf, founder and CEO, RaySearch, says: “I am happy that we have signed our first agreement with Mevion China and look forward to our collaboration and to be able to contribute to further improving the treatment for cancer patients at Tongji Hospital.”
For more information: www.raysearchlabs.com
April 10, 2026 
